62
Participants
Start Date
October 7, 2011
Primary Completion Date
November 20, 2011
Study Completion Date
November 20, 2011
Amoxicillin + MMX placebo
MMX placebo administered once a day (QD) orally on Days 1-3, then a single oral dose of Amoxicillin (500 mg) + MMX placebo on Day 4.
Amoxicillin + MMX mesalazine/mesalamine
MMX mesalazine/mesalamine (4.8 g) administered QD orally on Days 1-3, then a single oral dose of Amoxicillin (500 mg) + MMX mesalazine/mesalamine (4.8 g) on Day 4.
PRA International, Lenexa
Lead Sponsor
Shire
INDUSTRY